// App-Quantinova.ai

e22013 : Adjuvant systemic therapies for melanoma in Alberta: An early descriptive analysis of population characteristics and treatment outcomes.

Researchers

Presenter

  • Rodrigo Rigo

Principal Investigators

  • Kim Koczka

  • Atul Batra

  • Winson Y. Cheung

  • Jose Gerard Monzon

  • Tina Cheng

Medical Centers

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • All India Institute of Medical Sciences, New Delhi, India

  • BC Cancer Agency, Vancouver, BC, Canada

  • University of Calgary Tom Baker Cancer Centre, Calgary, AB, Canada

  • Tom Baker Cancer Center, Calgary, AB, Canada

Locations

  • Canada

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Dabrafenib Mesylate

  • Trametinib

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved